← Evidence map

ArticleClinical & translational immunology2021

Next-generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells.

Eris Bame et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34141433